Get started Log in

FRMM — Forum Markets Share News

0.000.00%

Last trade - 00:00

FinancialsSpeculativeMicro CapSucker Stock

Market Cap
$43.95m
Enterprise Value
$65.80m
Revenue
$6.55m

Brief: 180 Life Sciences Corp Files For Offering Of Up To 13.95 Million Shares By The Selling Stockholder - SEC Filing
31/01/2024 23:14
Brief: 180 Life Sciences Took Various Actions To Reduce Compensation Payable To Certain Of Its Service Providers
17/01/2024 13:39
Brief: 180 Life Sciences , Nasdaq Provided Company Written Notice That Company Has Complied With Terms Of Prior Extension
15/12/2023 13:33
Brief: 180 Life Sciences Engages AGP/Alliance Global Partners As Financial Advisor To Explore And Evaluate Strategic Alternatives
04/12/2023 14:16
Brief: 180 Life Sciences Announces Review Of Strategic Alternatives
28/11/2023 15:32
Brief: 180 Life SciencesOn Received Notice From Nasdaq,Co Not In Compliance With Shareholder Approval Requirements Set Forth In Listing Rule 5635(D)
13/10/2023 22:05
Brief: 180 Life Sciences Corp: Elected To Terminate Co's HMGB1 License Agreement With Oxford On Sept 22
28/09/2023 23:26
Brief: 180 Life Sciences says Court Ruled In Favor Of Co's Motion For Summary Judgment In Complaint Filed Against Tyche Capital Llc
22/09/2023 15:16
Brief: 180 Life Sciences Corp Says On Sept 7, Received Written Notice From The Listing Qualifications Department Of The Nasdaq Stock Market LLC
08/09/2023 21:35
Brief: 180 Life Sciences Corp. Announces Closing Of $3 Million Public Offering
14/08/2023 21:52
Brief: 180 Life Sciences Provides Update On Regulatory Approval Process In The Uk And Us For Dupuytren’S Disease Treatment Continues Consultations With The Uk Mhra And Initiates A Type C Meeting Request With The Us FDA
03/08/2023 14:21
Brief: 180 Life Sciences Corp Announces Filing Of Provisional Patent
31/07/2023 14:05
Brief: 180 Life Sciences Files For Offering Of Shares Of Common Stock With Common Warrants
16/06/2023 22:46
Brief: 180 Life Sciences Corp Says On April 27, Board Removed 'Interim' Title Of Ozan Pamir, Chief Financial Officer Of Co
28/04/2023 22:36
Brief: 180 Life Sciences Says Court Issued Order Granting In Part And Denying In Part Company's Motion For Partial Summary Judgment
26/04/2023 13:15
Brief: 180 Life Sciences Provides Update Regarding Anti-Tnf Frozen Shoulder Trial
22/02/2023 22:44
Brief: 180 Life Sciences-Co's I-Tnf Frozen Shoulder Trial, Including Recruitment Of Such Trial Closed By United Kingdom Nihr, With Only 9 Articipants
22/02/2023 22:34
Brief: 180 Life Sciences Engages Kinexum For Assistance In Applying For Marketing Authorisation In United Kingdom
17/01/2023 13:47
Brief: 180 Life Sciences Regains Compliance With Nasdaq Minimum Bid Price Requirement
05/01/2023 14:55
Brief: 180 Life Sciences Corp CEO James Woody Issues Letter To Shareholders
29/12/2022 13:40